Seropositive RA can present with two different types of autoantibodies that have distinct features: anti-citrullinated protein antibodies (ACPAs) and rheumatoid factors (RFs). With a single-cell approach, researchers provide evidence that the underlying B cell subsets of these autoantibody specificities develop in parallel by different mechanisms.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Neutrophils in chronic inflammatory diseases
Cellular & Molecular Immunology Open Access 17 January 2022
-
Rheumatoid arthritis patients display B-cell dysregulation already in the naïve repertoire consistent with defects in B-cell tolerance
Scientific Reports Open Access 27 December 2019
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Malmström, V., Catrina, A. I. & Klareskog, L. The immunopathogenesis of seropositive RA: from triggering to targeting. Nat. Rev. Immunol. 17, 60–75 (2017).
Falkenburg, W. J. J., von Richthofen, H. J. & Rispens, T. On the origin of rheumatoid factors: insights from analyses of variable region sequences. Semin. Arthritis Rheum. https://doi.org/10.1016/j.semarthrit.2018.06.006 (2018).
Titcombe, P. J. et al. Pathogenic citrulline-multispecific B cell receptor clades in rheumatoid arthritis. Arthritis Rheumatol. https://doi.org/10.1002/art.40590 (2018).
Elliott, S. E. et al. Affinity maturation drives epitope spreading and generation of pro-inflammatory anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheumatol. https://doi.org/10.1002/art.40587 (2018).
Vergroesen, R. D. et al. B cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation. Ann. Rheum. Dis. 77, 955–958 (2018).
Steen, J. et al. Human plasma cell derived monoclonal antibodies to post translationally modified proteins recognize amino acid motifs rather than specific proteins. Arthritis Rheumatol. https://doi.org/10.1002/art.40699 (2018).
Lu, D. R. et al. T cell dependent affinity maturation and innate immune pathways differentially drive autoreactive B cell responses in rheumatoid arthritis. Arthritis Rheumatol. https://doi.org/10.1002/art.40578 (2018).
Rombouts, Y. et al. Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis. Ann. Rheum. Dis. 75, 578–585 (2016).
Lloyd, K. A. et al. Variable domain N-linked glycosylation and negative surface charge are key features of monoclonal ACPA: implications for B cell selection. Eur. J. Immunol. 48, 1030–1045 (2018).
Roosnek, E. & Lanzavecchia, A. Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells. J. Exp. Med. 173, 487–489 (1991).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
V.M. declares that she has given lectures supported by pharmacological companies (BMS, Janssen, Pfizer and Sobis) within her duty at the Karolinska Institute (and with financial compensation to the Karolinska Institute). C.G. declares no competing interests.
Rights and permissions
About this article
Cite this article
Malmström, V., Grönwall, C. The parallel worlds of ACPA-positive and RF-positive B cells. Nat Rev Rheumatol 14, 626–628 (2018). https://doi.org/10.1038/s41584-018-0094-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-018-0094-5
This article is cited by
-
Neutrophils in chronic inflammatory diseases
Cellular & Molecular Immunology (2022)
-
Rheumatoid arthritis patients display B-cell dysregulation already in the naïve repertoire consistent with defects in B-cell tolerance
Scientific Reports (2019)